This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Pedro Gautier
Director of Process Validation at Agilent Technologies
Speaker

Profile

Pedro J. Gautier is a seasoned pharmaceutical leader with over 25 years of experience in process validation, CMC strategy, and GMP manufacturing. Currently serving as Process Validation Director at Agilent Technologies, he leads validation programs supporting commercial oligonucleotide API manufacturing. Throughout his career, Pedro has guided cross-functional teams through Stage 1–3 validation, regulatory submissions, and PPQ execution across biologics and advanced therapeutics. He previously held leadership roles at Novavax, Boehringer Ingelheim, Thermo Fisher Scientific, and Amgen. Pedro is recognized for building high-performing teams, implementing risk-based validation strategies, and delivering inspection-ready, science-driven solutions that accelerate commercialization while maintaining rigorous quality and compliance standards

Agenda Sessions

  • Validation Without the Guesswork: A Fit-for-Purpose Strategy for Oligonucleotide Manufacturing

    9:00am